News

Filter

Current filters:

Aggrastat

1 to 9 of 47 results

Iroko grants Chiesi rights to Aggrastat in 19 European countries

14-05-2009

USA-based Iroko Cardio has granted Italian drugmaker Chiesi Farmaceutici rights to market acute coronary…

AggrastatMerck KGaATirofiban

Early use of Merck & Co's Aggrastat benefits STEMI patients

08-09-2008

Early, in-ambulance treatment with antiplatelet agent, US drug major Merck & Co's Aggrastat (tirofiban…

AggrastatAspirinBayerheparinMerck KGaATirofiban

Iroko acquires rights to Merck & Co CV compound

04-02-2008

Philadelphia, USA-based Iroko Pharmaceuticals has acquired all non-US commercial rights to Aggrastat…

AggrastatheparinMerck KGaATirofiban

Medicure's 2nd-qtr sales fall on Aggrastat slump

21-01-2008

Canadian biopharmaceutical company Medicure says that total product revenue for the three-month period…

AggrastatAmino AcidsInjectionPhysostigmine SalicylateTirofiban

Medicure acquires US rights to Aggrastat

14-08-2006

Canadian biopharmaceutical company Medicure, a specialist in the field of cardiovascular drugs, says…

AggrastatAmino AcidsInjectionMerck KGaAMGI PharmaPhysostigmine SalicylateTirofiban

Merck & Co returns to India

01-08-2005

US drug major Merck & Co has said that it will restart operations at its wholly-owned subsidiary MSD…

AggrastatCancidasCaspofungin AcetateErtapenem InjectionInvanzMerck KGaAPneumococcal Vaccine PolyvalentPneumovaxTirofibanVaricella Virus Vaccine LiveVarivax

1 to 9 of 47 results

Back to top